These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19184352)

  • 1. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
    Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
    Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
    Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
    Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
    Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
    Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.
    Stio M; Martinesi M; Bruni S; Treves C; d'Albasio G; Bagnoli S; Bonanomi AG
    Int Immunopharmacol; 2006 Jul; 6(7):1083-92. PubMed ID: 16714211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colorectal disease by stool defensin assay: an exploratory study.
    Zou H; Harrington JJ; Sugumar A; Klatt KK; Smyrk TC; Ahlquist DA
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):865-8. PubMed ID: 17531545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of alpha- and beta-defensins in human ocular surface tissue.
    Ikeda A; Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2005; 49(2):73-8. PubMed ID: 15838720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal defensin expression during Candida infection and reflux disease.
    Kiehne K; Brunke G; Meyer D; Harder J; Herzig KH
    Scand J Gastroenterol; 2005 May; 40(5):501-7. PubMed ID: 16036501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.
    Ashitani J; Mukae H; Arimura Y; Sano A; Tokojima M; Nakazato M
    Life Sci; 2004 Jul; 75(9):1123-34. PubMed ID: 15207659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection.
    Shiomi K; Nakazato M; Ihi T; Kangawa K; Matsuo H; Matsukura S
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1336-44. PubMed ID: 8216266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.
    Kübler I; Koslowski MJ; Gersemann M; Fellermann K; Beisner J; Becker S; Rothfuss K; Herrlinger KR; Stange EF; Wehkamp J
    Aliment Pharmacol Ther; 2009 Sep; 30(6):621-33. PubMed ID: 19549264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease.
    Mishima Y; Ishihara S; Amano Y; Oshima N; Kadota C; Otani A; Moriyama I; Li YY; Aziz MM; Kinoshita Y
    Scand J Gastroenterol; 2009; 44(2):172-9. PubMed ID: 18830898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.